Years after $2B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia

5th September 2023 Uncategorised 0

Years after $2B buyout, Nestlé ditches Aimmune’s peanut allergy drug Palforzia
aliu
Tue, 09/05/2023 – 10:22

More: Years after B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia
Source: fierce